Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00186420
What this trial is testing

Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation

Who this might be right for
Prostate Cancer
Stanford University 13
Testing effectiveness (Phase 2)Looking for participantsNCT05054296
What this trial is testing

Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 200
Early research (Phase 1)Study completedNCT04995042
What this trial is testing

Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer

Who this might be right for
Hormone Sensitive Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd. 12
Testing effectiveness (Phase 2)Looking for participantsNCT05832086
What this trial is testing

Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

Who this might be right for
Prostate Adenocarcinoma
Stephen Freedland 138
Early research (Phase 1)Looking for participantsNCT05656573
What this trial is testing

CART-PSMA Cells for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Nova Therapeutics LLC 20
Not applicableLooking for participantsNCT06052683
What this trial is testing

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 208
Testing effectiveness (Phase 2)Study completedNCT00077402
What this trial is testing

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cancer Therapeutics Research Group 50
Large-scale testing (Phase 3)Study completedNCT00027859
What this trial is testing

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Not applicableNot Yet RecruitingNCT07096596
What this trial is testing

Prostate Cancer Study of Patient Experiences

Who this might be right for
Prostate Cancer
Ankara University 3,000
Not applicableLooking for participantsNCT06690970
What this trial is testing

Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients

Who this might be right for
PSMA-related DiseaseProstate CancerPositron Emission Tomography+3 more
Tianjin Medical University 500
Early research (Phase 1)Looking for participantsNCT07181473
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Lung Cancer (NSCLC)Prostate CancerEsophageal Cancer+1 more
Phrontline Biopharma 200
Not applicableUnknownNCT01311856
What this trial is testing

Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors

Who this might be right for
Breast CancerColorectal CancerProstate Cancer
M.D. Anderson Cancer Center 60
Not applicableUnknownNCT03880851
What this trial is testing

MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0)

Who this might be right for
Prostate Cancer
University Hospital Tuebingen 78
Testing effectiveness (Phase 2)Looking for participantsNCT02391051
What this trial is testing

Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial

Who this might be right for
Prostate Cancer
University of Erlangen-Nürnberg Medical School 50
Testing effectiveness (Phase 2)Study completedNCT00684905
What this trial is testing

Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Mayo Clinic 50
Not applicableUnknownNCT04521894
What this trial is testing

The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
First Affiliated Hospital Xi'an Jiaotong University 500
Not applicableStudy completedNCT05389202
What this trial is testing

Study of Prostate Perfusion Before Embolization in Patients With Symptomatic Prostate Adenoma

Who this might be right for
Prostate Cancer
Centre Hospitalier Universitaire de Nīmes 45
Large-scale testing (Phase 3)Study completedNCT02678351
What this trial is testing

68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Andrei Iagaru 74
Not applicableLooking for participantsNCT05847166
What this trial is testing

A Phase 2/3,PSMA-T4, Prostate Cancer

Who this might be right for
Prostate Cancer
NCBJ Polatom: Narodowe Centrum Badań Jądrowych Polatom 80
Testing effectiveness (Phase 2)Ended earlyNCT04635059
What this trial is testing

Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 6
Next Page